Medicilon is a professional preclinical integrated R&D contract research organization (CRO), providing a full range of one-stop R&D services, in compliance with international filing standards, to pharmaceutical companies and institutions around the world. Our services cover the entire process of preclinical drug development, including hit discovery, lead optimization and candidate selection. Our drug discovery services include chemical synthesis, compound activity screening and optimization, structural biology research and target validation. Preclinical services we provide include process and formulation development, quality standards and stability testing, and biomarker development. We also provide a full range of pharmacodynamic, pharmacokinetic and toxicological safety assessment to support IND applications.
We focus on meeting the innovation and development needs of the global drug development industry.